Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Isotopes and Radioisotopes01:28

Isotopes and Radioisotopes

10.9K
In the early 1900s, English chemist Frederick Soddy realized that an element could have atoms with different masses that were chemically indistinguishable. These different types are called isotopes — atoms of the same element that differ in mass. Isotopes differ in mass because they have different numbers of neutrons but are chemically identical because they have the same number of protons. Soddy was awarded the Nobel Prize in Chemistry in 1921 for this discovery.
An isotope containing...
10.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitral Transcatheter Edge-to-Edge Repair in Non-Surgical Candidates with Hypertrophic Obstructive Cardiomyopathy: Clip It, or Ablate It?

Journal of cardiovascular development and disease·2026
Same author

The Art of Kandinsky: Lessons in the Invisible and the Real.

Practical radiation oncology·2026
Same author

The Unseen Pillars of Precision: A Qualitative Study on Feedback, Communication, and Motivation Among Medical Technologists in Radiation Oncology.

Journal of cancer education : the official journal of the American Association for Cancer Education·2026
Same author

Three-Dimensional Radiation Therapy Target Volume Definitions for Osteoarthritis-Consensus Statement of the International Benign Target Volume Group.

International journal of radiation oncology, biology, physics·2026
Same author

Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/082, May 2025).

Geburtshilfe und Frauenheilkunde·2026
Same author

Glowing Beauty: Collecting Uranium Glass-Dangerous Liaisons?

Practical radiation oncology·2026
Same journal

Integrative Medicine for Breast Cancer Survivors.

Seminars in radiation oncology·2026
Same journal

Integrative Oncology Approaches for Gastrointestinal Symptoms and Risk Reduction in Patients With Digestive Tract Cancers.

Seminars in radiation oncology·2026
Same journal

Integrative Oncology and Radiation Therapy: An Essential Evolution.

Seminars in radiation oncology·2026
Same journal

Clinical Trials of Integrative Oncology Interventions for Radiation Therapy: Emerging Evidence and Opportunities.

Seminars in radiation oncology·2026
Same journal

Nonpharmacologic Approaches for Pain Management in Patients With Cancer Treated With Radiation Therapy.

Seminars in radiation oncology·2026
Same journal

Integrative Therapies for Radiation-Related Toxicities in Hematological Malignancies.

Seminars in radiation oncology·2026
See all related articles

Related Experiment Video

Updated: Jan 8, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K

Radiotherapy for Other Nonmalignant Diseases.

Isabel Falke1, Ulrich Schäfer2, Oliver Micke3

  • 1Ludgerus Kliniken, Münster, Germany.

Seminars in Radiation Oncology
|December 14, 2025
PubMed
Summary
This summary is machine-generated.

Radiotherapy is increasingly used for benign diseases, showing efficacy in pain reduction with low toxicity. Further research is needed for rare conditions to assess long-term outcomes and quality of life.

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.6K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.8K

Related Experiment Videos

Last Updated: Jan 8, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.6K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.8K

Area of Science:

  • Oncology
  • Radiology
  • Benign Diseases

Background:

  • Radiotherapy is increasingly utilized for nonmalignant conditions, particularly in Germany.
  • Over 50% of radiation treatments are for benign diseases like osteoarthritis and Dupuytren's disease.
  • Low-dose radiotherapy demonstrates efficacy in pain reduction and disease stabilization with minimal toxicity.

Purpose of the Study:

  • To evaluate the efficacy and safety of radiotherapy for benign diseases.
  • To review current evidence for rare indications and identify research gaps.

Main Methods:

  • Review of current literature on radiotherapy for benign conditions.
  • Analysis of evidence for rare diseases, including case series and retrospective studies.

Main Results:

  • Low-dose radiotherapy is effective for common benign conditions, offering pain relief and stabilization.
  • Evidence for rare indications like Gorham-Stout disease is limited, necessitating further investigation.
  • Radiotherapy is generally safe for benign diseases when applied appropriately, with late effects requiring monitoring.

Conclusions:

  • Radiotherapy is a viable treatment option for various benign diseases.
  • More randomized trials are essential to establish long-term outcomes and quality of life for patients.
  • Collaborative data collection and biological studies are crucial for rare disease research.